NCT00222183View on ClinicalTrials.gov

Cutaneous Lupus Erythematosus and Elidel

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

June 30, 2003

Conditions
Lupus Erythematosus, CutaneousLupus Erythematosus, Discoid
Interventions
DRUG

Elidel (pimecrolimus)

Trial Locations (1)

04103

Department of Dermatology, University of Leipzig, Leipzig

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

University of Leipzig

OTHER

NCT00222183 - Cutaneous Lupus Erythematosus and Elidel | Biotech Hunter | Biotech Hunter